Big Bite: Biden demands insurance companies cover medical "gender-affirming care" after the FDA added a warning to puberty blockers
Big bite | A detailed dive into big news
July 1
On July 1, the Food and Drug Administration (FDA) added a warning to multiple gonadotropin-releasing hormone (GnRH) agonists, drugs often used as puberty blockers in gender-confused youth.
The FDA identified six cases where there was a “plausible” link between GnRH agonists and a condition called pseudotumor cerebri, which is caused by elevated fluid pressure in the brain.
According to the FDA, all six cases were identified in biologically female children between the ages of 5 and 12; five of the six were being treated for early puberty, and the sixth was undergoing “transgender care.”
According to the Daily Wire, symptoms included specifically, “visual disturbances, headaches, and vomiting.” In addition, “Other effects GnRH agonists caused were an increase in blood pressure, brain swelling, and abducens neuropathy.”
July 18
On July 18, a clip of Biden's Assistant Secretary for Health Rachel Levine speaking about youth gender affirmation treatment w…
Keep reading with a 7-day free trial
Subscribe to It's Meseidy to keep reading this post and get 7 days of free access to the full post archives.